II. Mechanism
- Live attenuated virus Vaccine
III. Indications: Travel to Yellow Fever endemic areas
- Sub-Saharan Africa
- Amazon basin of South America
IV. Dose: Patient over age 9 months
- Dose: 0.5 ml subcutaneous every 10 years
V. Contraindications
-
Immunocompromised Patient
- HIV Infection
- Immunosuppressive medications
- Pregnancy (relative contraindication)
- Infant under age 6 months
- Hypersensitivity to egg products
VI. Efficacy
- Effective in 100% of patients for 10 years